Leonardo DRS Insider Filing: 4,403 Shares From Restricted Stock to Be Sold

Rhea-AI Filing Summary

Leonardo DRS (DRS) filing reports a planned sale of 4,403 shares of common stock. The shares were acquired by the seller on 06/01/2024 through restricted stock vesting as compensation and are scheduled to be sold through Fidelity Brokerage Services LLC on NASDAQ on 08/20/2025. The filing shows an aggregate market value of $181,271.51 against 266,123,634 shares outstanding, and the seller attests they are not aware of any undisclosed material adverse information. The notice reports no other sales by this person in the past three months.

Positive

• Compliant disclosure: The filing follows Rule 144 format and identifies broker, acquisition method, and planned sale date.
• Vested compensation origin: Securities were acquired through restricted stock vesting on 06/01/2024, indicating the sale is of previously awarded compensation rather than a new issuance.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine insider sale of vested equity; immaterial to company valuation given the small share percentage.

The filing documents a proposed sale of 4,403 shares valued at $181,271.51 that were received via restricted stock vesting on 06/01/2024 and are to be sold through Fidelity on NASDAQ on 08/20/2025. Compared with 266,123,634 shares outstanding, the position represents a de minimis fraction of equity, so the transaction is unlikely to meaningfully affect market capitalization or liquidity. The filing follows Rule 144 disclosure protocols and includes the seller's attestation regarding material information.

Corporate Governance Expert

TL;DR: Proper Rule 144 disclosure of vested compensation aligns with compliance expectations; no governance red flags present.

The notice specifies that the securities were acquired via restricted stock vesting and identifies the broker and planned sale date, which satisfies typical insider reporting requirements. There are no concurrent sales reported in the prior three months and the signer attests to the absence of undisclosed material information. From a governance perspective this is standard executive/employee equity monetization rather than an indicator of material concern.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4403	181271.51	266123634	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2024	Restricted Stock Vesting	Issuer			4403	06/01/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the DRS Form 144 report propose to sell?

The filing proposes the sale of 4,403 common shares through Fidelity Brokerage Services LLC.

When were the shares acquired and how were they acquired according to the filing?

The shares were acquired on 06/01/2024 by restricted stock vesting and were granted as compensation.

What is the aggregate market value and planned sale date for the shares in the filing?

The aggregate market value is reported as $181,271.51 and the approximate date of sale is 08/20/2025.

How many shares outstanding does the filing report for DRS?

The filing lists 266,123,634 shares outstanding.

Does the filing indicate other sales by the person in the past three months?

No, the filing states Nothing to Report for securities sold during the past three months.